BNS Q2 2026 Earnings Transcript

Bank of Nova Scotia reported adjusted earnings of $2.7 billion, or $2.02 per share, with ROE rising to 13.2% and CET1 at 13.3% after repurchasing 6.4 million shares. Management raised the quarterly dividend by $0.04 and reiterated $7.5 billion of capital returned over the past 12 months, while also highlighting broad revenue growth and efficiency gains. Offsetting the strong results, credit guidance turned more cautious: impaired PCLs are now expected to settle in the mid-50 bps range for the rest of 2026 amid inflation, trade uncertainty, and a one-off corporate impairment in International Banking.

Analysis

BNS is finally getting rewarded for a multi-year mix shift: the earnings quality is improving because the bank is pulling profitability out of funding mix, fee density, and cross-sell rather than just asset growth. The second-order implication is that its revenue sensitivity is becoming less rate-dependent than the market likely assumes; that should reduce the stock’s beta to lower-for-longer rates and make the name more resilient if Canada growth softens.

The bigger near-term debate is credit. Management’s willingness to push impaired guidance higher while emphasizing episodic rather than systemic stress usually means the P&L is absorbing late-cycle clean-up, not the start of a broad loss cycle. That matters because if the one-off international file truly is idiosyncratic, consensus may be overstating the durability of elevated provisions into 2027, creating room for earnings revisions once the seasonal/macro noise fades over the next 1-2 quarters.

Capital allocation is the underappreciated catalyst. With buybacks still prioritized and leverage improving, the bank can shrink the equity base even if top-line growth normalizes, which is the cleanest path to multiple expansion in a sector that is still priced like capital is scarce. The AI rollout is not a near-term earnings driver, but it is an important signal that expense growth should stay contained while productivity improves; that supports a higher-through-the-cycle ROE and gives management more flexibility to keep returning capital without sacrificing organic investment.

The contrarian view is that the market may be underestimating how much of the upside is already in the quarterly optics and overestimating how quickly commercial growth and credit normalization translate into clean EPS beats. In other words, this is probably a 6-12 month re-rating story, not a 1-2 quarter trade, and the stock can still be volatile if macro headlines reaccelerate deposit competition or consumer stress.

Key Decisions for Investors

• Long BNS common on weakness over the next 2-4 weeks; use any post-earnings digestion to add, targeting a 10-15% total return over 6-9 months if provisions stabilize and buybacks persist.
• Pair trade: long BNS / short CM over 3-6 months; BNS has more visible operating leverage and capital-return torque, while CM’s relative upside is more dependent on a cleaner macro reacceleration.
• Sell 3-6 month out-of-the-money BNS puts if volatility remains elevated; credit story looks more idiosyncratic than cyclical, so downside should be buffered unless Canadian consumer stress broadens materially.
• For event-driven exposure, consider a small call spread in BNS into the next 1-2 quarters; the thesis is multiple expansion on capital return plus reserve normalization, with defined downside if credit worsens instead of moderates.